LAI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 4.712
EU - Europa 2.174
AS - Asia 1.110
AF - Africa 51
SA - Sud America 42
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 4
Totale 8.108
Nazione #
US - Stati Uniti d'America 4.640
IT - Italia 1.320
SG - Singapore 486
IN - India 293
SE - Svezia 188
CN - Cina 181
FI - Finlandia 161
UA - Ucraina 105
DE - Germania 80
GB - Regno Unito 58
CA - Canada 54
ID - Indonesia 49
FR - Francia 46
IE - Irlanda 44
NL - Olanda 42
TG - Togo 39
BG - Bulgaria 37
AR - Argentina 30
IR - Iran 30
MX - Messico 17
PL - Polonia 17
RO - Romania 17
TR - Turchia 17
PH - Filippine 16
AU - Australia 14
HK - Hong Kong 10
RU - Federazione Russa 10
ZA - Sudafrica 9
AT - Austria 8
ES - Italia 8
BE - Belgio 7
BR - Brasile 7
IL - Israele 6
AL - Albania 5
EU - Europa 4
JP - Giappone 4
PT - Portogallo 4
KR - Corea 3
MK - Macedonia 3
NO - Norvegia 3
PE - Perù 3
CH - Svizzera 2
CY - Cipro 2
EE - Estonia 2
GR - Grecia 2
IQ - Iraq 2
KZ - Kazakistan 2
LT - Lituania 2
MD - Moldavia 2
PK - Pakistan 2
SA - Arabia Saudita 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BJ - Benin 1
CL - Cile 1
CO - Colombia 1
DZ - Algeria 1
EG - Egitto 1
JM - Giamaica 1
MY - Malesia 1
NZ - Nuova Zelanda 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 8.108
Città #
Fairfield 666
Chandler 424
Rome 385
Singapore 379
Ashburn 282
Woodbridge 259
Seattle 236
Houston 196
Cambridge 193
Wilmington 190
Princeton 150
Santa Clara 139
Ann Arbor 113
Plano 107
Dearborn 103
Beijing 93
San Paolo di Civitate 93
Pittsburgh 76
Boston 70
Lawrence 68
Millbury 67
Milan 64
Helsinki 63
New York 58
San Diego 58
Andover 49
Dublin 44
Jakarta 44
Lomé 39
Caserta 37
Sofia 37
Fremont 36
Jacksonville 34
Naaldwijk 27
Norwalk 27
Federal 26
Boardman 23
Ottawa 22
Falls Church 21
Frankfurt am Main 19
Toronto 19
Afragola 16
Rocca d'Evandro 14
Zanjan 14
Falkenstein 12
Phoenix 12
Southend 12
Des Moines 11
Bühl 10
Hefei 10
Leawood 10
Sacramento 10
Kunming 9
Palermo 9
Cesenatico 8
Lafayette 8
Mannheim 8
Marano Di Napoli 8
Melbourne 8
Paris 8
Pune 8
Simi Valley 8
Bologna 7
Brussels 7
Hyderabad 7
Johannesburg 7
Lappeenranta 7
Medford 7
Nanjing 7
Bremen 6
Buffalo 6
Guangzhou 6
Guidonia 6
Hong Kong 6
Latina 6
London 6
Los Angeles 6
Mumbai 6
Naples 6
Pearland 6
Redwood City 6
San Mateo 6
Vienna 6
Bergamo 5
Cellole 5
Chengdu 5
Florence 5
Fort Worth 5
Henderson 5
Jinan 5
Moscow 5
Napoli 5
Selçuklu 5
Shenyang 5
Soncino 5
Stockholm 5
Torino 5
Winnipeg 5
Avezzano 4
Brescia 4
Totale 5.465
Nome #
ENCEFALOPATIA UREMICA NELLA MALATTIA RENALE IN TERAPIA CONSERVATIVA E SOSTITUTIVA. 186
Psychological, emotional and social impairments are associated with adherence and healthcare spending in type 2 diabetic patients: an observational study 174
Neurological, psychological, and cognitive disorders in patients with chronic kidney disease on conservative and replacement therapy 130
Un caso di gammapatia biclonale di incerto significato 125
Biventricular assessment of light-chain amyloidosis using 3D speckle tracking echocardiography: differentiation from other forms of myocardial hypertrophy 118
Eventi di perdita e lutto complicato: verso una definizione di disturbo da sofferenza prolungata per il DSM-5 111
Emotional self-efficacy and alexithymia may affect compliance, renal function and quality of life in kidney transplant recipients: results from a preliminary cross-sectional study 110
Early markers of cardiovascular risk in autosomal dominant polycystic kidney disease 106
Predittori psicologici del rigetto d’organo 101
Cardio-Renal Syndrome Type 4: The Correlation Between Cardiorenal Ultrasound Parameters. 100
Attachment style predict compliance, quality of life and renal function in adult patients after kidney transplant. Preliminary results 99
Tenofovir-related nephropathies in HIV-infected patients 98
Emotional management and biological markers of dietetic regimen in chronic kidney disease patients 96
The metabolite beta-aminoisobutyric acid and physical inactivity among hemodialysis patients 95
Magnetic resonance imaging 3t and total fibrotic volume in autosomal dominant polycystic kidney disease 94
Neurological and psychological changes in hemodialysis patients before and after the treatment 89
Notch3-regulated microRNAs impair CXCR4-dependent maturation of thymocytes allowing maintenance and progression of T-ALL 88
Cardiac, inflammatory and metabolic parameters: hemodialysis versus peritoneal dialysis. 88
Vascular endothelial growth factor inhibitor therapy and cardiovascular and renal damage in renal cell carcinoma 88
Effects of Switching from Twice-Daily to Once-Daily Tacrolimus Formulation on Quality of Life, Anxiety, and Transplant Benefit Perception after Kidney Transplantation 87
Atherosclerotic ischemic renal disease. Diagnosis and prevalence in an hypertensive and/or uremic elderly population. 86
Hyperaldosteronism and cardiovascular risk in patients with autosomal dominant polycystic kidney disease 84
Dataset on the use of 3D speckle tracking echocardiography in light-chain amyloidosis 83
Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis 82
Female gender and overestimation of glomerular filtration rate: independent predictors of acute kidney injury after liver transplantation
 82
Emotional management and quality of life in mother living versus multi-organ donor renal transplant recipients 81
Locoregional surgery in metastatic breast cancer. Do concomitant metabolic aspects have a role on the management and prognosis in this setting? 79
Preoperative Psychological Factors Predicting Graft Rejection in Patients Undergoing Kidney Transplant: A Pilot Study 78
Color-Doppler sonography in ophthalmology 77
Nephroangiosclerosis and Its Pharmacological Approach 75
Loss of Renal Function After Retrograde Ureteral Placement of an Allium Stent for Severe Ureteral Stricture 75
Chronic kidney disease-epidemiology formula and model for end-stage liver disease score in the assessment of renal function in candidates for liver transplantation 75
Reduction in Heart Rate Variability in Autosomal Dominant Polycystic Kidney Disease 75
Adult patients affected by cystic fibrosis in therapy with cystic fibrosis transmembrane regulator modulators and lung transplant: renal function, metabolic and nutritional status 75
Peritoneal dialysis in older adults: evaluation of clinical, nutritional, metabolic outcomes, and quality of life 74
“A young man with persistent myalgia and fatigue: an off-label therapeutic approach”. 74
Externally oriented thinking predicts phosphorus levels in dialyzed patients 73
Color doppler ultrasound guidance during renal angioplasty and stenting 73
Sarcopenia and cardiovascular risk indices in patients with chronic kidney disease on conservative and replacement therapy 73
Longitudinal physical activity change during hemodialysis and its association with body composition and plasma BAIBA levels 73
HYPERALDOSTERONISM AND CARDIOVASCULAR RISK IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE 71
COMPLIANCE NEI PAZIENTI IN DIALISI E SOTTOPOSTI A TRAPIANTO DI RENE 70
Long-term Glomerular Filtration Rate and Kidney Disease: Improving Global Outcomes Stage Stability After Conversion to Once-Daily Tacrolimus in Kidney Transplant Recipients 69
α-lipoic acid in patients with autosomal dominant polycystic kidney disease 67
Modeling the contribution of male testosterone levels to the duration of positive COVID testing among hospitalized male COVID-19 patients 67
Resistive Index and MELD-Na: Nephrologic Monitoring in Cirrhotic Patients Awaiting Liver Transplantation 66
Corrigendum: Effect of Underlying Renal Disease on Nutritional and Metabolic Profile of Older Adults with Reduced Renal Function 65
Revascularization versus medical therapy for renal artery stenosis: Antihypertensive drugs and renal outcome 65
Compliance and quality of life in chronic key disease 64
Association between multidimensional prognostic index and hospitalization and mortality among older adults with chronic kidney disease on conservative or on replacement therapy 64
Use of enoxaparin in end-stage renal disease 63
CORRELAZIONI CLINICO-PATOLOGICHE ED OUTCOME RENALE IN 19 PAZIENTI CON VASCULITE PAUCIIMMUNE 62
Glomerulonephritis, Pathogenetic Mechanisms and Therapeutic Options: An Overview 62
GERIATRIC NEPHROLOGY: AN OVERVIEW 62
Epicardial fat thickness in patients with autosomal dominant polycystic kidney disease 62
Atherosclerotic ischemic renal disease 60
SUN-P123: Beta-Aminoisobutyric Acid in Physical Inactivity Among Hemodialysis Patients 60
“EARLY MARKERS OF CARDIOVASCULAR RISK IN CHRONIC KIDNEY DISEASE” 59
Increase of renal resistive index and mineral metabolism disorder in patients with acute coronary syndrome with preserved renal function 58
PLOS ONE 2017 Reviewer and Editorial Board Thank You. 57
Effect of low-protein diet and inulin on microbiota and clinical parameters in patients with chronic kidney disease 57
SIMULTANEA PRESENTAZIONE DI GLOMERULONEFRITE FIBRILLARE E SINDROME DI TOLOSA-HUNT 56
null 56
Effect of underlying renal disease on nutritional and metabolic profile of older adults with reduced renal function 56
Vitamin D deficiency, insulin resistance, and ventricular hypertrophy in the early stages of chronic kidney disease 55
null 54
Anti-infiammatori non steroidei: utilizzo topico nel trattamento della xeroftalmia secondaria s sindrome di Sjogren (Non steroidal anti-inflammatory drugs: Topical application on treatment of xerophtalmia in Sjogren's syndrome) 52
Nephropathies in HIV-infected patients: an overview 52
Ischemic nephropathy: proteinuria and renal resistance index could suggest if revascularization is recommended 52
Effect of personalized dietary intervention on nutritional, metabolic and vascular indices in patients with chronic kidney disease. 52
Disfunzione endoteliale, calcificazioni vascolari e aterosclerosi nei primi stadi dell'insufficienza renale cronica: ruolo dell'uricemia, dell'omocisteinemia e del metabolismo Ca-P. 52
Total Parathyroidectomy with Subcutaneous Parathyroid Forearm Autotransplantation in the Treatment of Secondary Hyperparathyroidism: A Single-Center Experience. 51
Cholemic nephropathy as cause of acute and chronic kidney disease. Update on an under-diagnosed disease 50
Chronic kidney disease and urological disorders: systematic use of uroflowmetry in nephropathic patients 49
Sleeve gastrectomy and one-year outcomes: Impact on cardiovascular, renal and metabolic parameters 48
A Rare Case of Complete-Immunotherapy-Responsive Metastatic Non-Small Cell Lung Cancer with Long Lasting Progression-Free Survival: A Case Report 47
Il consenso informato in aferesi:il punto di vista del nefrologo. 47
null 47
Contrast-Induced Acute Kidney Injury and Endothelial Dysfunction: The Role of Vascular and Biochemical Parameters 46
Un caso di trapianto di rene in Sindrome di Alport: possibile ruolo dell’ipogammaglobulinemia iatrogena nella produzione di anticorpi anti-membrana basale glomerulare 46
Resistant hypertension and obstructive sleep apnea syndrome in therapy with continuous positive airway pressure: Evaluation of blood pressure, cardiovascular risk markers and exercise tolerance 46
Expected and observed glomerular filtration rates in kidney transplant patients converted to once daily tacrolimus: 10 years of follow-up 46
[Optimal use of peritoneal dialysis with multi-disciplinary management]. 45
Prebiotic Therapy with Inulin Associated with Low Protein Diet in Chronic Kidney Disease Patients: Evaluation of Nutritional, Cardiovascular and Psychocognitive Parameters 45
Stenosi dell'arteria renale associata ad iperomocisteinemia. Case report 45
null 45
Effects of non-invasive ventilation on renal and endothelial function in patients with respiratory failure 45
CKD-EPI and MDRD To Evaluate Glomerular Filtration Rate in Liver Transplant Candidates 44
Chronic kidney disease as a systemic inflammatory syndrome: update on mechanisms involved and potential treatment 44
COMPLIANCE AND QUALITY OF LIFE IN CHRONIC KIDNEY DISEASE. 43
UREMIC ENCEPHALOPATHY IN CHRONIC KIDNEY DISEASE IN CONSERVATIVE AND REPLACEMENT THERAPY. 42
“ENCEFALOPATIA UREMICA NELLA MALATTIA RENALE” 42
Screening of QTc interval and global autonomic activity in autosomal dominant polycystic kidney disease and atherosclerotic renal artery stenosis hypertensive patients 41
Assessment of renal microcirculation in biopsy-proven tubulointerstitial nephritis in patients with and without glomerular disease: the role of resistive index 41
Effects of sunitinib on endothelial dysfunction, metabolic changes, and cardiovascular risk indices in renal cell carcinoma 40
Ischemic nephropaty: the role of the renal artery stenosis re-vascularization on renal stem cells 40
Parasympathetic activity and total fibrotic kidney in autosomal-dominant polycystic kidney disease patients: a pilot study 39
Beta-aminoisobutyric acid as a biomarker of physical inactivity among hemodialysis patients. 39
Renal resistive index in IgA nephropathy and renal scleroderma vasculopathy 39
Acute Kidney Injury in Monoclonal Gammopathies 39
Totale 6.878
Categoria #
all - tutte 27.298
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.298


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020983 0 0 0 0 0 187 187 223 150 114 65 57
2020/2021915 80 64 39 51 38 86 84 111 105 170 55 32
2021/20221.526 60 69 108 43 191 47 47 125 117 110 263 346
2022/20231.458 278 291 63 169 151 140 33 82 139 11 67 34
2023/2024975 40 124 64 64 74 136 50 83 19 100 86 135
2024/2025984 128 189 164 167 200 136 0 0 0 0 0 0
Totale 8.596